PAM
PALI icon

Panagora Asset Management’s Palisade Bio PALI Stock Holding History

Panagora Asset Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1
Closed -$17K – 2552
2018
Q4 		$17K Buy
+1
New +$57.4K ﹤0.01% 2244
2018
Q3 		– Hold
0
– – – 2126
2018
Q2 		– Hold
0
– – – 2111
2018
Q1 		– Hold
0
– – – 2039
2016
Q1 		– Hold
0
– -$31K – 2328
2015
Q4 		– Hold
0
– – – 2086
2015
Q3 		– Hold
0
– – – 2057
2014
Q2 		– Hold
0
– -$500K – 2369
2014
Q1 		– Hold
0
– – – 1416

Other funds holding PALI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Panagora Asset Management's PALI Position: Q1 2019 in Review

Panagora Asset Management sold out of Palisade Bio (PALI) in Q1 2019, closing a stake of 1 share — an estimated $17K sold.

Panagora Asset Management first reported a position in PALI in Q4 2018 and held it in 1 quarter. The position peaked at $17K in Q4 2018. 7 funds tracked by Wall St. Rank hold PALI as of Q1 2019.

  • Panagora Asset Management reported no remaining Palisade Bio position as of Q1 2019 after selling out during the quarter.
  • Panagora Asset Management sold 1 Palisade Bio share in Q1 2019, an estimated $17K.
  • Panagora Asset Management first reported a position in Palisade Bio in Q4 2018 and held it in 1 quarter.
  • Panagora Asset Management's Palisade Bio position peaked at $17K in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2019.

Based on Panagora Asset Management's 13F filing for Q1 2019, filed 15 May 2019.